Portugal Ventures investment in Magnomics is feautured on “Jornal OJE” (Portuguese only)

“ESTES NOVOS investimentos da Portugal Ventures são o resultado da Call For Entrepreneurship da capital de risco. E foram realizados em parceria com outros investidores: A Faber Investments, gerida pela Faber Ventures co-investiu na SABE Online, a PNV Capital na Zuvinova e na Magnomics, a Busy Angels na Zuvinova e a Beta Capital apostou na Magnomics.”

Jornal OJE edição 18JUL14

Magnomics first international coverage, by Animal Pharm

“The company’s device consists of a portable reader with inbuilt sample treatment. A sample such as a swab, urine or milk is inserted into the device and, after bacteria separation and DNA purification, DNA amplification is performed by the technology.”

“There are no molecular point-of-care tests available for bovine mastitis,” said Mr Cardoso. “There are some molecular techniques used in laboratories but they are expensive. There are also some tests that use chemical reactions to detect mastitis at the farm, but these are too broad and the commonly used cell culturing tests are too slow with results in 24 to 48 hours.”

View full article in Animal Pharm

Magnomics attends BIO 2014

“Magnomics was selected to be part of the largest Portuguese delegation ever to attend the Bio International Convention 2014, in San Diego, California, from the 23rd to the 26th of June. With the support of Biocant, a key national biotechnology park, and P-BIO, the Portuguese Association for Bioindustry, Magnomics was one of 12 companies at the center stage of the Portuguese presence in what is considered to be one of the main events for biotechnology in the world.”

Download PDF

Contact Us

Praesent faucibus nisl sit amet nulla sollicitudin pretium a sed purus. Nullam bibendum porta magna.